1. Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors. (June 2019) Authors: Wesolowski, Robert; Sharma, Neelesh; Reebel, Laura; Rodal, Mary Beth; Peck, Alexandra; West, Brian L.; Marimuthu, Adhirai; Severson, Paul; Karlin, David A.; Dowlati, Afshin; Le, Mai H.; Coussens, Lisa M.; Rugo, Hope S. Journal: Therapeutic advances in medical oncology Issue: Volume 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Emerging importance of dietary phytochemicals in fight against cancer: Role in targeting cancer stem cells. Issue 16 (2nd November 2017) Authors: Singh, Amit Kumar; Sharma, Neelesh; Ghosh, Mrinmoy; Park, Yang Ho; Jeong, Dong Kee Journal: Critical reviews in food science and nutrition Issue: Volume 57:Issue 16(2017) Page Start: 3449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer. (25th August 2015) Authors: Halmos, Balazs; Pennell, Nathan A.; Fu, Pingfu; Saad, Shumaila; Gadgeel, Shirish; Otterson, Gregory A.; Mekhail, Tarek; Snell, Michael; Kuebler, J. Philip; Sharma, Neelesh; Dowlati, Afshin Journal: Oncologist Issue: Volume 20:Number 11(2015) Page Start: 1298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Prognostic potential of neutrophil-to-lymphocyte ratio and lymphocyte nadir in stage III non-small-cell lung cancer. (July 2017) Authors: Kang, Kylie H; Efird, Jimmy T; Sharma, Neelesh; Yang, Michael; Dowlati, Afshin; Linden, Philip; Machtay, Mitchell; Biswas, Tithi Journal: Future oncology Issue: Volume 13:Number 16(2017) Page Start: 1405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Optimum treatment for mediastinal lymph node positive (N2) resectable non-small cell lung cancer: what is the role for surgery?. Issue 11 (1st November 2016) Authors: Awan, Musaddiq; Sharma, Neelesh; Towe, Christopher W.; Efird, Jimmy T.; Machtay, Mitchell; Biswas, Tithi Journal: Expert review of anticancer therapy Issue: Volume 16:Issue 11(2016) Page Start: 1131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib‐Responsive Non‐Small Cell Lung Cancer. (25th August 2015) Authors: Halmos, Balazs; Pennell, Nathan A.; Fu, Pingfu; Saad, Shumaila; Gadgeel, Shirish; Otterson, Gregory A.; Mekhail, Tarek; Snell, Michael; Kuebler, J. Philip; Sharma, Neelesh; Dowlati, Afshin Journal: Oncologist Issue: Volume 20:Number 11(2015) Page Start: 1298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EP294/#883 Elimusertib, an oral ataxia telangiectasia and RAD3-related inhibitor, in advanced gynecologic cancers with DNA damage response defects. (4th December 2022) Authors: Tan, David S; Castonguay, Vincent; Cote, Gregory; Bono, Johann S De; El-Rayes, Bassel; Gabrail, Nashat; Iwasa, Satoru; Joerger, Markus; Jones, Robert; Sawyer, Michael B; Shapiro, Geoffrey I; Tan, Daniel; Merz, Claudia; Uttenreuther, Regina; Jeffers, Michael; Ferraldeschi, Roberta; Sharma, Neelesh... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Controversies in the management of stage III non-small-cell lung cancer. Issue 3 (March 2014) Authors: Biswas, Tithi; Sharma, Neelesh; Machtay, Mitchell Journal: Expert review of anticancer therapy Issue: Volume 14:Issue 3(2014) Page Start: 333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase II study of erlotinib and docetaxel with concurrent intensity‐modulated radiotherapy in locally advanced head and neck squamous cell carcinoma. (26th February 2016) Authors: Yao, Min; Woods, Charles; Lavertu, Pierre; Fu, Pingfu; Gibson, Michael; Rezaee, Rod; Zender, Chad; Wasman, Jay; Sharma, Neelesh; Machtay, Mitchell; Savvides, Panayiotis Journal: Head & neck Issue: Volume 38(2016)Supplement 1 Page Start: E1770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer. (17th February 2019) Authors: Bhateja, Priyanka; Chiu, Michelle; Wildey, Gary; Lipka, Mary Beth; Fu, Pingfu; Yang, Michael Chiu Lee; Ardeshir‐Larijani, Fatemeh; Sharma, Neelesh; Dowlati, Afshin Journal: Cancer medicine Issue: Volume 8:Number 4(2019:Apr.) Page Start: 1459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗